Mental Health and Psychosocial Care Grief and Loss

"There's no time limit on grief:" Women's perspectives on a novel reproductive grief screening tool

Bute JJ, Brann M, Buskmiller C, Fredenburg M

Published December 15, 2023 PEC Innovation, 3, 100244
DOI 10.1016/j.pecinn.2023.100244 PMID 38076488 PMC PMC10704326

RRM Academy Synopsis

Women with pregnancy loss viewed a brief grief screen favorably

In a mixed-methods study of 27 interviewed and 282 surveyed U.S. women with pregnancy loss, participants viewed a five-item Reproductive Grief Screen favorably and found it validating. About 7 out of 10 surveyed women believed a provider check-in about coping would help. Most preferred completing the screen online before an appointment.

Key Findings

  • The study included 27 women in online interviews (23 in focus groups, 4 in individual interviews) and 282 survey respondents; 153 (54.3%) of the survey respondents had a miscarriage.
  • Of 282 survey respondents, 208 (73.8%) said their current provider knew about their loss; 18.1% said the provider did not know and 7.8% were unsure.
  • In the survey, 72% believed a provider check-in about coping after pregnancy loss would be helpful. For screening frequency, 35.1% recommended monthly in the first year and 47.5% annually afterward.
  • Electronic completion was preferred before arriving at the facility (57.4%) or during the exam (21.3%); 30.1% chose a patient portal and 27.3% a text message link.
  • Preferred completion method varied with age (χ2(30, N = 277) = 93.61, p < .001) and with time since loss (p < .05).

Interpretation

This mixed-methods study combined online focus groups, individual interviews, and a national survey to learn how women wanted a reproductive grief screen used in their care. Recruitment ran through reproductive loss support websites and social media. The authors note that their sample skewed White (77.3% of survey respondents). The findings support larger, more diverse studies of this screening approach.

RRM Context

Restorative reproductive medicine looks for the cause of a loss in both partners, and the emotional history belongs in that picture. Survey respondents reported gaps: 25.9% said their provider did not know of the loss or they were unsure. Women in the study thought the five-item screen could promote communication about grief between women and their providers.

Abstract

Objective

Women who have experienced reproductive loss (i.e., miscarriage, stillbirth, abortion) evaluated the usefulness of a novel screening tool, Reproductive Grief Screen (RGS), to identify patients struggling with ongoing, complicated grief.

Methods

This mixed-methods study involved U.S. women who had experienced reproductive loss. Online data collection resulted in 27 interviews and 282 surveys completed. Perceptions of and preferences about RGS were thematically analyzed. Chi square analyses assessed relationships between demographics and tool preferences.

Results

RGS validated women's experiences with grief after reproductive loss. Women noted their providers may be unaware of their loss(es). Participants requested periodic screening using RGS beginning shortly after a loss (or during new patient intake) and occurring regularly (e.g., annually). Overall, women preferred completing RGS online before an appointment, though preferences varied by demographics (i.e., age, time since loss). Participants want providers to compassionately discuss RGS results with them and offer appropriate resources.

Conclusion

The RGS can help identify largely ignored grief after reproductive loss.

Innovation

Findings from group and individual interviews and a survey of women who have coped with reproductive loss suggest that use of a brief RGS tool could reshape clinical practice to aid women who might be facing complicated grief. Moreover, women expressed clear preferences for how to implement use of the RGS in clinical contexts.

Topics

By this author

Related research

Mental Health and Psychosocial Care › Grief and Loss › Bereavement Care
Jennifer J Bute, Maria Brann, Cara Buskmiller, Michaelene Fredenburg
Jen Bute, Jenny Bute, J Bute, M Brann, C Buskmiller, M Fredenburg
PMID 38076488 38076488 DOI 10.1016/j.pecinn.2023.100244 10.1016/j.pecinn.2023.100244 Bute et al. 2023, Bute 2023